These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32119084)

  • 1. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
    Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
    Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.
    Häsler J; Flajnik MF; Williams G; Walsh FS; Rutkowski JL
    Mol Immunol; 2016 Jul; 75():28-37. PubMed ID: 27213814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
    Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
    Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a pH-Sensitive IgNAR Variable Domain from a Yeast-Displayed, Histidine-Doped Master Library.
    Könning D; Zielonka S; Sellmann C; Schröter C; Grzeschik J; Becker S; Kolmar H
    Mar Biotechnol (NY); 2016 Apr; 18(2):161-7. PubMed ID: 26838965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
    Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
    Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
    Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
    Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development.
    Ubah OC; Barelle CJ; Buschhaus MJ; Porter AJ
    Curr Pharm Des; 2016; 22(43):6519-6526. PubMed ID: 27604606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
    Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
    Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
    Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
    Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
    Jiang X; Sun S; Li Z; Chen M
    Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
    Dooley H
    Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring shark VNAR antibody against infectious diseases using phage display technology.
    Lim HT; Kok BH; Leow CY; Leow CH
    Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights and biomedical potential of IgNAR scaffolds from sharks.
    Zielonka S; Empting M; Grzeschik J; Könning D; Barelle CJ; Kolmar H
    MAbs; 2015; 7(1):15-25. PubMed ID: 25523873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancient species offers contemporary therapeutics: an update on shark V
    English H; Hong J; Ho M
    Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
    Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
    Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope.
    Zielonka S; Empting M; Könning D; Grzeschik J; Krah S; Becker S; Dickgießer S; Kolmar H
    Mar Biotechnol (NY); 2015 Aug; 17(4):386-92. PubMed ID: 26003538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
    Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
    Front Immunol; 2022; 13():953917. PubMed ID: 36177031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerisation strategies for shark IgNAR single domain antibody fragments.
    Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
    J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.
    Müller MR; Saunders K; Grace C; Jin M; Piche-Nicholas N; Steven J; O'Dwyer R; Wu L; Khetemenee L; Vugmeyster Y; Hickling TP; Tchistiakova L; Olland S; Gill D; Jensen A; Barelle CJ
    MAbs; 2012; 4(6):673-85. PubMed ID: 23676205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and next-generation sequencing analysis of a large phage-displayed V
    Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
    Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.